The CRESONATE brand, founded in 2005 (United States), from 30 sister brands and 2617 competing brands. CRESONATE is a brand of Lantheus Hldg., listed on the stock exchange of New York. CRESONATE is part of the Medical Diagnostics & Research activity sector.

Share price and profitability of the share Lantheus Hldg. (CRESONATE)

Buy Lantheus Hldg. share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 65.58

Portfolio valuation
Lantheus Hldg. (CRESONATE) over 5 years* USD 175.27

Stock market history Lantheus Hldg. (CRESONATE)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Lantheus Hldg.

NEUROLITE
NEUROLITE
See more brands of Lantheus Hldg.

Rival brands
CRESONATE

PARAKITO
PARAKITO
Gendx
Gendx
Diagnostic International Distribution
Diagnostic International Distribution
Synaffix
Synaffix
SonoVol
SonoVol
Oxford Immunotec
Oxford Immunotec
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking